6.37
price up icon2.41%   0.15
after-market Dopo l'orario di chiusura: 6.50 0.13 +2.04%
loading

Myriad Genetics Inc Azioni (MYGN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
8.78%
213.10
195.90 210.60 213.30 211.50
Cost Of Revenue
0.65%
61.30
61.70 59.70 63.50 64.40
Gross Profit
13.11%
151.80
134.20 150.90 149.80 147.10
Operating Expenses
194.73%
481.00
163.20 189.90 169.80 183.60
Benefits Costs and Expenses
141.32%
543.70
225.30 249.70 234.50 248.70
Costs And Expenses
141.32%
543.70
225.30 249.60 233.30 248.00
Depreciation and Amortization
2.08%
14.10
14.40 14.80 15.60 15.10
Operating Income/Loss
1,035%
-329.20
-29.00 -39.00 -20.00 -36.50
Nonoperating Income/Loss
250.00%
-1.40
-0.40 -0.10 -1.20 -0.70
Income/Loss From Continuing Operations Before Tax
1,024%
-330.60
-29.40 -39.10 -21.20 -37.20
Income Tax Expense/Benefit
99.66%
-0.10
-29.30 3.40 0.90 -0.50
Income/Loss From Continuing Operations After Tax
330.40K%
-330.50
-0.10 -42.50 -22.10 -36.70
Net Income/Loss
330.40K%
-330.50
-0.10 -42.50 -22.10 -36.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.20%
92.50
91.40 0.10 90.90 90.60
Diluted Average Shares
1.20%
92.50
91.40 0.10 90.90 90.60
Basic Earnings Per Share
-3.57
- -0.47 -0.24 -0.41
Diluted Earnings Per Share
-3.57
- -0.47 -0.24 -0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$301.80
price up icon 1.39%
diagnostics_research DGX
$181.64
price up icon 1.36%
$168.25
price up icon 0.22%
diagnostics_research LH
$277.99
price up icon 0.98%
diagnostics_research MTD
$1,301.04
price up icon 1.40%
diagnostics_research IQV
$190.81
price up icon 1.10%
Capitalizzazione:     |  Volume (24 ore):